https://www.avient.com/products/polymer-additives/uv-and-light-blocking-additives/colormatrix-lactra-sx-light-blocking-additive-pet
Color and Additives Solutions Overview
Colorant and additives overview and capabilities
https://www.avient.com/knowledge-base/article/boosting-rpet-quality-and-safety-packaging?psfam[]=22049
Avient has developed a "Heat Stability Protocol" to screen new additive solutions for their impact on color and NIAS through two full recycle loops at 100% recycled content.
This provides minimal effect on color shift and product safety.
https://www.avient.com/knowledge-base/article/boosting-rpet-quality-and-safety-packaging?pname[]=22232
Avient has developed a "Heat Stability Protocol" to screen new additive solutions for their impact on color and NIAS through two full recycle loops at 100% recycled content.
This provides minimal effect on color shift and product safety.
https://www.avient.com/knowledge-base/article/boosting-rpet-quality-and-safety-packaging?sust[]=1137
Avient has developed a "Heat Stability Protocol" to screen new additive solutions for their impact on color and NIAS through two full recycle loops at 100% recycled content.
This provides minimal effect on color shift and product safety.
https://www.avient.com/sites/default/files/2023-01/Mevopur Healthcare Colorants and Formulations Special Effects Application Bulletin_0.pdf
Mevopur™ Healthcare Colorants and Formulations
Special Effect Colorants for Healthcare Devices and
Pharmaceutical Packaging
Self-administered medication, for example via
pen devices and inhalers, has been the norm for
many years.
Ingredients used in the
Mevopur™ portfolio have been tested to industry
standards that support applications in both
medical devices and pharmaceutical packaging.*
KEY CHARACTERISTICS
• Manufactured at four ISO 13485 certified
manufacturing sites, providing global
consistency and increased security of supply
• Documented change control beyond CAS
number, reducing risk of change
• Non-phthalate and formulated without
animal-derived substances
• Available as pre-colored formulation or
concentrate and for use in different polymers
REGULATORY SUPPORT
• Raw materials tested to:
- ISO 10993-1 and USP biological
evaluation
- European Pharmacopeia 3.1.3/3.1.5
(polyolefin)
- USP (polyethylene)
- ICH Q3D elemental impurities
• Registered Drug Master File (Type III) and/or
Device Master File
• Food contact established with FDA/EU**
APPLICATION BULLETIN
* Design note: Effect colors require careful consideration of part design and
polymer flow paths to minimize visible flow lines.
https://www.avient.com/sites/default/files/2022-07/Avient 2021 Sustainability Report 7-26-22.pdf
Board of Directors
Gender
Female 25%
Male 75%
Age
30–50 17%
Over 50 83%
Race & Ethnicity
U.S.
Calculate color corrections to meet a target color
3.
Define PCR color specification limits and find PCR grades to achieve a target color
4.
https://www.avient.com/industries
We can also help you navigate the regulatory environment for your industry, and you can take advantage of our expertise in polymer science, colorants and design to address emerging trends for market share gains.
https://www.avient.com/sites/default/files/2021-01/certificate-of-amendment-modification-avient-colorants-canada-inc.pdf
Certificate of Amendment
Loi canadienne sur les sociétés par actionsCanada Business Corporations Act
Certificat de modification
Avient Colorants Canada Inc.
942266-8
Corporate name / Dénomination sociale
Corporation number / Numéro de société
Raymond Edwards
Date of amendment (YYYY-MM-DD)
Date de modification (AAAA-MM-JJ)
Director / Directeur
2021-01-15
I HEREBY CERTIFY that the articles of the
above-named corporation are amended under
section 178 of the Canada Business
Corporations Act as set out in the attached
articles of amendment.
Corporation number
Numéro de la société
2
942266-8
The articles are amended as follows
Les statuts sont modifiés de la façon suivante
3
The corporation changes its name to:
La dénomination sociale est modifiée pour :
Avient Colorants Canada Inc.
https://www.avient.com/investor-center/news/polyone-appoints-giuseppe-di-salvo-vice-president-investor-relations-justin-m-hess-vice-president-corporate-controller
in 2011 as assistant controller, a position he held until being named director of finance for the company's Color, Additives and Inks business segment.
He joined the company in 2010 and has since advanced through progressively increasing roles of global responsibility, including external reporting manager; assistant corporate controller; finance director for Color, Additives and Inks; and finance director for
https://www.avient.com/company/sustainability/sustainability-report/products/markets/healthcare-case-study
Mevopur™ Healthcare Bio-Based Polymer Solutions are color and performance-enhancing additive solutions formulated with bio-based polymers for healthcare applications.
Remafin™ EP White Colorants for Pharmaceutical Packaging designed for a range of pharmaceuticals, safeguarding light transmission while meeting regulatory requirements.